Management of chemotherapy-induced peripheral neuropathy (Q36533580)

14 August 2017

1 reference

title

Management of chemotherapy-induced peripheral neuropathy (English)

1 reference

14 August 2017

1 reference

Mark Stillman

1

1 reference

PubMed ID

16834943

14 August 2017

Juan P Cata

series ordinal

2

1 reference

PubMed ID

16834943

14 August 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

Current Pain and Headache Reports

14 August 2017

1 reference

14 August 2017

10

1 reference

14 August 2017

279-287

1 reference

14 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s11916-006-0033-z

14 August 2017

0 references

cites work

Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale

1 reference

https://api.crossref.org/works/10.1007%2FS11916-006-0033-Z

Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-006-0033-Z

Neurologic complications of cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-006-0033-Z

Peripheral neuropathy secondary to docetaxel (Taxotere)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-006-0033-Z

Thalidomide-induced neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-006-0033-Z

Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-006-0033-Z

Glutamine as a neuroprotective agent in high-dose paclitaxel-induced peripheral neuropathy: a clinical and electrophysiologic study

21 January 2018

1 reference

12 December 2020

Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine

1 reference

12 December 2020

Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy

1 reference

12 December 2020

Grading of chemotherapy-induced peripheral neuropathy

1 reference

12 December 2020

Chemotherapy-induced peripheral neuropathy: an increasing concern for oncologists

1 reference

12 December 2020

Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer

1 reference

12 December 2020

Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies

1 reference

12 December 2020

Medication and toxin-induced peripheral neuropathy

1 reference

12 December 2020

Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies

1 reference

12 December 2020

Peripheral neurotoxicity of taxol in patients previously treated with cisplatin

1 reference

12 December 2020

Neurophysiological study of peripheral neuropathy after high-dose Paclitaxel: lack of neuroprotective effect of amifostine

1 reference

12 December 2020

Spinal glial glutamate transporters downregulate in rats with taxol-induced hyperalgesia.

1 reference

12 December 2020

Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer

1 reference

12 December 2020

Can we do a better job preventing clinically-relevant peripheral neuropathy resulting from carboplatin/paclitaxel chemotherapy?

1 reference

12 December 2020

Toxic neuropathy in patients with pre-existing neuropathy

1 reference

12 December 2020

Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing

1 reference

12 December 2020

Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients

1 reference

12 December 2020

Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy.

1 reference

12 December 2020

Altered discharges of spinal wide dynamic range neurons and down-regulation of glutamate transporter expression in rats with paclitaxel-induced hyperalgesia

1 reference

12 December 2020

Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A.

1 reference

12 December 2020

Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study

1 reference

12 December 2020

Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations

1 reference

12 December 2020

Prevention of chemotherapy-induced neuropathy: leukemia inhibitory factor

1 reference

12 December 2020

Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy.

1 reference

12 December 2020

A prospective study of suramin-induced peripheral neuropathy

1 reference

12 December 2020

Peripheral neuropathy induced by administration of cisplatin- and paclitaxel-based chemotherapy. Could it be predicted?

1 reference

12 December 2020

Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy

1 reference

12 December 2020

Association of Paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer

1 reference

12 December 2020

Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy

1 reference

12 December 2020

Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine

1 reference

12 December 2020

The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20

1 reference

12 December 2020

A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy

1 reference

12 December 2020

Taxol produces a predominantly sensory neuropathy

1 reference

12 December 2020

Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy

1 reference

12 December 2020

Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy

1 reference

12 December 2020

A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy

1 reference

12 December 2020

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

1 reference

12 December 2020

The effects of an ACTH (4-9) analogue on development of cisplatin neuropathy in testicular cancer: a randomized trial

1 reference

12 December 2020

Inhibition of glutamate uptake in the spinal cord induces hyperalgesia and increased responses of spinal dorsal horn neurons to peripheral afferent stimulation

1 reference

12 December 2020

Oxaliplatin-induced neurotoxicity and the development of neuropathy

1 reference

12 December 2020

10.1007/S11916-006-0033-Z

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16834943